Literature DB >> 25808873

Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer.

Monther Abu-Remaileh1, Sebastian Bender2, Günter Raddatz2, Ihab Ansari1, Daphne Cohen1, Julian Gutekunst2, Tanja Musch2, Heinz Linhart3, Achim Breiling2, Eli Pikarsky4, Yehudit Bergman5, Frank Lyko6.   

Abstract

Chronic inflammation represents a major risk factor for tumor formation, but the underlying mechanisms have remained largely unknown. Epigenetic mechanisms can record the effects of environmental challenges on the genome level and could therefore play an important role in the pathogenesis of inflammation-associated tumors. Using single-base methylation maps and transcriptome analyses of a colitis-induced mouse colon cancer model, we identified a novel epigenetic program that is characterized by hypermethylation of DNA methylation valleys that are characterized by low CpG density and active chromatin marks. This program is conserved and functional in mouse intestinal adenomas and results in silencing of active intestinal genes that are involved in gastrointestinal homeostasis and injury response. Further analyses reveal that the program represents a prominent feature of human colorectal cancer and can be used to correctly classify colorectal cancer samples with high accuracy. Together, our results show that inflammatory signals establish a novel epigenetic program that silences a specific set of genes that contribute to inflammation-induced cellular transformation. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25808873     DOI: 10.1158/0008-5472.CAN-14-3295

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

Review 1.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

Authors:  Yutaka Hashimoto; Timothy J Zumwalt; Ajay Goel
Journal:  Epigenomics       Date:  2016-04-22       Impact factor: 4.778

2.  Mismatch Repair Proteins Initiate Epigenetic Alterations during Inflammation-Driven Tumorigenesis.

Authors:  Ashley R Maiuri; Michael Peng; Ram Podicheti; Shruthi Sriramkumar; Caitlin M Kamplain; Douglas B Rusch; Christina E DeStefano Shields; Cynthia L Sears; Heather M O'Hagan
Journal:  Cancer Res       Date:  2017-05-18       Impact factor: 12.701

3.  Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.

Authors:  Pan Pan; Kiyoko Oshima; Yi-Wen Huang; Kimberle A Agle; William R Drobyski; Xiao Chen; Jianying Zhang; Martha M Yearsley; Jianhua Yu; Li-Shu Wang
Journal:  Int J Cancer       Date:  2018-03-30       Impact factor: 7.396

4.  Emerging Role of Nutri-Epigenetics in Inflammation and Cancer.

Authors:  Paule V Joseph; Sarah K Abey; Wendy A Henderson
Journal:  Oncol Nurs Forum       Date:  2016-11-01       Impact factor: 2.172

5.  Cellular context-dependent consequences of Apc mutations on gene regulation and cellular behavior.

Authors:  Kyoichi Hashimoto; Yosuke Yamada; Katsunori Semi; Masaki Yagi; Akito Tanaka; Fumiaki Itakura; Hitomi Aoki; Takahiro Kunisada; Knut Woltjen; Hironori Haga; Yoshiharu Sakai; Takuya Yamamoto; Yasuhiro Yamada
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-05       Impact factor: 11.205

6.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

Review 7.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12

Review 8.  Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Authors:  Andrew P Feinberg; Michael A Koldobskiy; Anita Göndör
Journal:  Nat Rev Genet       Date:  2016-03-14       Impact factor: 53.242

Review 9.  The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?

Authors:  Marco Puzzoni; Nicola Silvestris; Francesco Leone; Riccardo Giampieri; Luca Faloppi; Laura Demurtas; Emanuela Dell'Aquila; Donatella Marino; Oronzo Brunetti; Silvio Ken Garattini; Elena Ongaro; Giorgio Astara; Laura Orgiano; Giuseppe Aprile; Daniele Santini; Mario Scartozzi
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493

10.  Longitudinal Study of DNA Methylation of Inflammatory Genes and Cancer Risk.

Authors:  Brian Thomas Joyce; Tao Gao; Lei Liu; Yinan Zheng; Siran Liu; Wei Zhang; Frank Penedo; Qi Dai; Joel Schwartz; Andrea A Baccarelli; Lifang Hou
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.